Mitoquinone mesylate as post-exposure prophylaxis against SARS-CoV-2 infection in humans: an exploratory single center pragmatic open label non-randomized pilot clinical trial with matched controls

Autor: Chen, Keren, Jackson, Nicholas J., Kelesidis, Theodoros
Zdroj: In eBioMedicine April 2024 102
Databáze: ScienceDirect